Share Name Share Symbol Market Type Share ISIN Share Description
Fusionex LSE:FXI London Ordinary Share JE00B8BL8C53 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 150.00p 148.00p 152.00p 150.00p 148.50p 148.50p 27,467.00 08:00:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 77.0 28.4 58.0 2.6 70.95

Fusionex (FXI) Latest News

More Fusionex News
Fusionex Takeover Rumours

Fusionex (FXI) Share Charts

1 Year Fusionex Chart

1 Year Fusionex Chart

1 Month Fusionex Chart

1 Month Fusionex Chart

Intraday Fusionex Chart

Intraday Fusionex Chart

Fusionex (FXI) Discussions and Chat

Fusionex Forums and Chat

Date Time Title Posts
11/1/201722:50Fusionex International plc1,147.00
06/1/201715:56FUSIONEX - the new Altitude!3.00
04/3/200910:14China shares, the etf4.00

Add a New Thread

Fusionex (FXI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Fusionex trades in real-time

Fusionex (FXI) Top Chat Posts

Fusionex Daily Update: Fusionex is listed in the Software & Computer Services sector of the London Stock Exchange with ticker FXI. The last closing price for Fusionex was 150p.
Fusionex has a 4 week average price of 154.71p and a 12 week average price of 169.70p.
The 1 year high share price is 352.50p while the 1 year low share price is currently 105p.
There are currently 47,300,000 shares in issue and the average daily traded volume is 34,722 shares. The market capitalisation of Fusionex is £70,950,000.
sheep_herder: Erm, yes, but if you got the EPS wrong then you also got the PER wrong. They report in Malaysian Ringitt but the share price is in GBP. Does that get you closer to the solution? ;-)
zcaprd7: No "we have no idea why the share price rise" release then?
shores: Laptop15 No idea! If you tell me the numbers ie sales and profit I can give you my answer. But from their history and associations all looks positive. Try to bear in mind however that they have forecast significant investment for growth which will be a drain on cash and affect any profitability as some accountants present the numbers that way. The trick is to sift out the capital investment and get to the true profit which is the basis for market capital valuation and hence what the share price should be. QED
laptop15: Shores, how do u think the results are going to be and how do u expect the share price to react? I'm expecting a rise and good results!
1628386: I actually agree with you both. The basis of what I am suggesting isn't based on II's or brokers. Where the conversation diverted on to that was their surprise at the investment cost impacting P&L. The recent investor exit (inflexion Point) has clearly damaged the share price though and so their thoughts are important as they have the ability to drive the share price down or up. As for George O'Connor, his target is 744p which is 50% more than mine so agree he is bullish. Nevertheless we can't argue with him being well respected. He was recognised in the investment industry as being the top tech analyst for small companies in 2013.
simon gordon: 162, I am slightly confused, in a previous post you stated that the Fundies would have known at the time of the capital raising that FXI would be loss making as they invested for turnover growth. Now you suggest that large investors are annoyed and that a BoD roadshow will settle this and help get FXI re-rated. If say FXI did 10p in 2018, and utilised most of their cash for expansion, that would put them on a p/e of 50x to make your 500p target in 2016. That's an incredibly rich rating for a company that was on a lower rating prior to the warning. How do you square this peg? A big share price boost would come if someone wanted to take them over, that's the wild card that could get them toward 320p+, about where they were before the profits warning.
1628386: Current position.... In all the research I've completed including contact with the company, there appears to be three reasons why the share price fell sharply. 1. The increase in receivables within the year end report spooked the market as it appeared to suggest there was an issue with collecting money owed to them. 2. Panmure Gordon then put out an update which was actually meant as an upgrade to 744p from 722p. However the analyst forecast that the company's expansion plans will lead to a loss in 2016 3. Because of point 2, a large investor (Inflection Point Investments) was not happy at all and decided to sell out. They had 2m shares and to shift and clearly needed to drop their sell price substantially to generate enough buying. So where are we now? Point 1 (above) was cleared up with an RNS from management confirming that they have collected 80% of the receivables since year end so that clears that up. Point 2 & 3 caused the damage and therefore leaving us at 155p now Inflexion Point have sold out. 155p values the company at £72.8m, a massive drop from the £155m it was worth the day before the results (an £82m drop to be precise!) To expose how irrational this is, let's say 2016 profit was forecast at £5.5m before the analyst took out the red pen.... Is a loss of £5.5m profit in one year really worth knocking £82m of the market value of the company? They raised £14m in October last year at £3.25 per share to fund the growth so they are adequately financed and they currently have £27m cash in the bank! They've been about as prudent as you could get. Did investors think the £14m was raised just to sit in the bank? It was raised to invest in a hugely growing market. The reason of the loss is because the company is growing very quickly and operating costs of investment in 2016 will increase as they open new offices and hire staff. The future years profit (post 2016) will clearly benefit from this. This is not a loss due to a declining business or margin erosion... It's a loss caused by huge growth and one of confidence in a massively growing market. You only have to read the CEO & Chairmans forecast to see how optimistic they are. The analyst himself upgraded the share price forecast to £7.44. Once Inflection Point have sold out, we are left with dented investor confidence as the share price fell so quickly. Some shareholders will have panicked and sold, others are bruised. To support the recovery period and repair the damage, the company have hinted the CEO will embark on a series of roadshows with investors aimed at restoring confidence (remember he owns 47% of the company so he's down £41m himself on the share price drop) Also, confidence will improve when the contract wins are announced and new products such as GIANT V2 are rolled out. The deal with Dell will also lead to the announcement of contract wins. All this regular positive newsflow to come. Lastly, to build confidence you generally need to look at track record. Just read the RNS's since flotation in 2012, the track record is there for all to see. The company was on a 32% growth rate BEFORE the fully funded expansion plans! The trajectory is huge. That's why I'm very confident we will see a return to £3 and then a push on towards £5. Panmure remember are forecasting £7.44
edsullyjoe: From GCI This share price fall looks like a mystery that would test Hercule Poirot, given the bullish stock exchange announcement just hours beforehand. However if Poirot was a client of Fusionex’s broker Panmure Gordon, he wouldn’t need his little grey cells to decipher what’s going on. Fusionex is embarking on a significant investment programme across the business in order to accelerate revenue growth. The upshot is that rather than making healthy profits this year and next, it will be loss-making. Earnings of 56.3 Malaysian ringgit (about 9.1p) per share previously expected for 2016 now becomes a loss per share of 36.4 ringgit. This is clearly a vitally important piece of information; yet it was released in a broker’s note; rather than being in the stock exchange announcement. Clearly this is not the right way to go about things. Price sensitive information should be released through the official channels and made available to all investors at the same time. The rules are clear on this. It’s hard to understand what Fusionex’s advisers were thinking of.
simon gordon: Proactive Investors - 21/1/16: Gorilla or marmoset: Fusionex divides broker opinion Better than expected sales of its GIANT Big Data product sales underpinned the figures Fusionex (LON:FXI) was subject to a keen debate after results from the ‘Big Data’ company beat expectations but the share price tumbled. Panmure Gordon analyst George O’Connor is a major fan and believes Fusionex has the potential to be a ‘gorilla’; in the Big Data market. The Malaysian software house increased sales by 35% to Rm77mln (£12.3mln) in the year to September, while profits rose to Rm28.4mln from Rm22.8mln. Better than expected sales of its GIANT Big Data product sales underpinned the figures, which O’Connor said beat both his revenue and earnings forecasts. The company recently raised £14mln through a placing, and a new GIANT product family is expected this year alongside a more channel-led sales model and wider geographic expansion, O’Connor added. Ivan Teh, the company's chief executive, said: “The new financial year has started on a very strong note with good new wins already secured for GIANT, as announced, coupled with a very strong pipeline, and therefore the outlook for 2016 and beyond is very positive and exciting for Fusionex." Peter McNally at Shore Capital was more cautious. “While consensus estimates are likely to be upgraded and the company is showing significant growth, we think the shares are still too expensive.” The earnings multiple is 34 times he said, which is compounded by the capitalisation of development costs. “EBITDA growth is 24.8% by our calculations on a “clean” basis,” said McNally. Panmure raised its target price to 744p, but Shore Cap’s view held more sway today as the shares fell 15% to 288p.
broadwood: Fusionex International has noted the drop in its share price after yesterday's announcement of its preliminary results for the year ended 30 September. The company says it understands that the share price may have been affected by commentary regarding perceived poor cash collection in the period and the directors wish to clarify the position. Cash collection for the year was adversely affected by an increase in trade receivables as a result of the business moving increasingly to channel partners which enable Fusionex to support scalable growth and wider market reach. These channel partners however require extended terms of trade, which is not unusual in the software industry and has resulted in this increase in receivables. Since the year end, and in the ordinary course of business, RM23.4m (GBP3.8m) of the year-end receivables of RM28.5m (GBP4.6m) has been collected
Fusionex share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170116 15:08:02